Occudo Quantitative Strategies LP Mersana Therapeutics, Inc. Transaction History

Occudo Quantitative Strategies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$4.0 - $7.02 $88,508 - $155,331	-22,127 Reduced 27.14%	59,411 $244,000
Q4 2022 Feb 14, 2023	SELL	$5.65 - $7.86 $172,257 - $239,635	-30,488 Reduced 27.22%	81,538 $477,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $430,451 - $743,760	92,970 Added 487.88%	112,026 $757,000
Q2 2022 Aug 15, 2022	SELL	$2.84 - $5.0 $338,414 - $595,800	-119,160 Reduced 86.21%	19,056 $88,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $516,927 - $916,372	138,216 New	138,216 $551,000

121

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $192M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.